These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 12920044

  • 1. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
    Khorana AA, Sahni A, Altland OD, Francis CW.
    Arterioscler Thromb Vasc Biol; 2003 Nov 01; 23(11):2110-5. PubMed ID: 12920044
    [Abstract] [Full Text] [Related]

  • 2. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
    Marchetti M, Vignoli A, Russo L, Balducci D, Pagnoncelli M, Barbui T, Falanga A.
    Thromb Res; 2008 Nov 01; 121(5):637-45. PubMed ID: 17692905
    [Abstract] [Full Text] [Related]

  • 3. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
    Collen A, Smorenburg SM, Peters E, Lupu F, Koolwijk P, Van Noorden C, van Hinsbergh VW.
    Cancer Res; 2000 Nov 01; 60(21):6196-200. PubMed ID: 11085545
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
    Vignoli A, Marchetti M, Balducci D, Barbui T, Falanga A.
    Haematologica; 2006 Feb 01; 91(2):207-14. PubMed ID: 16461305
    [Abstract] [Full Text] [Related]

  • 5. Effects of sera, basic fibroblast growth factor, heparin and cyclic AMP-stimulation on proliferation of human vascular endothelial cells.
    Gillis C, Jonzon B, Haegerstrand A.
    Cell Mol Biol (Noisy-le-grand); 1995 Dec 01; 41(8):1131-8. PubMed ID: 8747094
    [Abstract] [Full Text] [Related]

  • 6. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.
    Chabut D, Fischer AM, Colliec-Jouault S, Laurendeau I, Matou S, Le Bonniec B, Helley D.
    Mol Pharmacol; 2003 Sep 01; 64(3):696-702. PubMed ID: 12920206
    [Abstract] [Full Text] [Related]

  • 7. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
    Xue L, Shireman PK, Hampton B, Burgess WH, Greisler HP.
    J Surg Res; 2000 Aug 01; 92(2):255-60. PubMed ID: 10896831
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of cell growth and inhibition of prostacyclin production by heparin in human umbilical vein endothelial cells.
    Hasegawa N, Yamamoto M, Yamamoto K.
    J Cell Physiol; 1988 Dec 01; 137(3):603-7. PubMed ID: 3056961
    [Abstract] [Full Text] [Related]

  • 9. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
    Martinez-Sales V, Vila V, Réganon E, Oms JG, Aznar J.
    Haematologica; 2003 Jun 01; 88(6):694-9. PubMed ID: 12801846
    [Abstract] [Full Text] [Related]

  • 10. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins.
    Hämmerle H, Betz E, Herr D.
    Vasa; 1991 Jun 01; 20(3):207-15. PubMed ID: 1659056
    [Abstract] [Full Text] [Related]

  • 11. Heparin inhibition of human vascular smooth muscle cell hyperplasia.
    Chan P, Mill S, Mulloy B, Kakkar V, Demoliou-Mason C.
    Int Angiol; 1992 Jun 01; 11(4):261-7. PubMed ID: 1338338
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
    Kazi M, Lundmark K, Religa P, Gouda I, Larm O, Ray A, Swedenborg J, Hedin U.
    J Cell Physiol; 2002 Dec 01; 193(3):365-72. PubMed ID: 12384988
    [Abstract] [Full Text] [Related]

  • 13. Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis.
    de la Rebière G, Franck T, Deby-Dupont G, Salciccia A, Grulke S, Péters F, Serteyn D.
    Vet J; 2008 Oct 01; 178(1):62-9. PubMed ID: 17942351
    [Abstract] [Full Text] [Related]

  • 14. [Protective effect of polysaccharide sulfate on human umbilical vein endothelial cell (HUVEC) injury in vitro].
    Hu MW, Zhou XB, Zhang LH, Xu HY.
    Yao Xue Xue Bao; 1995 Oct 01; 30(9):641-5. PubMed ID: 8701737
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor.
    Mousa SA, Mohamed S.
    Thromb Haemost; 2004 Sep 01; 92(3):627-33. PubMed ID: 15351861
    [Abstract] [Full Text] [Related]

  • 16. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
    Keledjian K, Garrison JB, Kyprianou N.
    J Cell Biochem; 2005 Feb 01; 94(2):374-88. PubMed ID: 15526277
    [Abstract] [Full Text] [Related]

  • 17. Low-molecular-weight heparins and angiogenesis.
    Norrby K.
    APMIS; 2006 Feb 01; 114(2):79-102. PubMed ID: 16519745
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium.
    McGuire TR, Kazakoff PW, Hoie EB, Fienhold MA.
    Pharmacotherapy; 1996 Feb 01; 16(2):237-44. PubMed ID: 8820467
    [Abstract] [Full Text] [Related]

  • 19. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 20. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B, Ni J, Vatish M, Singer DR.
    Microcirculation; 2008 Apr 15; 15(3):251-67. PubMed ID: 18386220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.